Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).
about
Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug WithdrawalRole of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-AnalysisThe association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseasesSurgical outcomes of Korean ulcerative colitis patients with and without colitis-associated cancerFunctional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.Cancer and immunomodulators in inflammatory bowel diseases.Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases.Systematic review of cuff and pouch cancer in patients with ileal pelvic pouch for ulcerative colitis.Ulcerative colitis: current pharmacotherapy and future directions.The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.Colon cancer screening and surveillance in inflammatory bowel disease.A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn's disease.Surveillance strategies for colitis-associated cancer: state of the art and future perspectives.UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.Recurrence and survival rates of inflammatory bowel disease-associated colorectal cancer following postoperative chemotherapy: a comparative study.Colorectal neoplasia in IBD--a single-center analysis of patients undergoing proctocolectomy.The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies.The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD group.Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.Next-generation sequencing: recent applications to the analysis of colorectal cancer.The risk of colorectal cancer is related to frequent hospitalization of IBD in an Asian population: results from a nationwide study.[A two-faced vitamin : Folic acid - prevention or promotion of colon cancer?]The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinoma.Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal CancersLarge bowel cancer in the setting of inflammatory bowel disease
P2860
Q26801119-9F77FD3A-29D9-4EB2-AE17-8947B0096D77Q28067664-8DAEBA4A-46D4-4545-955E-585558C33353Q33731916-E7BEE9F0-CCE1-494A-8A3C-6EFF85DA43B8Q33857049-35A48424-B7F2-4628-9619-3F6126108D36Q34979766-9A670D3B-428D-47BE-A5A4-B1217597230EQ35221792-CC52B224-B801-4E23-B968-B28FB48AD70EQ35271319-C8334C65-15A2-4466-9E5B-446AD3861300Q35534959-39AA1102-730D-417A-8A84-5E5B7F85189FQ36084130-655042E2-9DED-4F4A-AEAD-801BED67CE96Q37018514-D500BC3C-A670-404C-8E5E-0A29231F44C3Q37716897-BFBEFA42-E31D-4D91-9E55-CD5163472580Q38200461-B599141A-5747-4511-A618-068B4D24778DQ38217653-C75002DB-168D-4B68-952F-735CA0319522Q38224247-8571A5B8-D0F1-436E-8A58-8B265E3E2BAAQ38288038-860C58FE-5586-45E9-BEA9-F4DB50B0D2D2Q38592330-BC2654CC-265F-4B60-98B3-DF7623A19235Q38748390-D2048FEC-D0A0-4375-9A4D-83A5E1817381Q38881708-1208EC95-2BB8-40AB-8F26-8C870083E686Q39697807-0B560F85-6A75-4E39-A910-D7BC7FF9364DQ41012134-C0D56A73-8571-4683-BAA9-19BFE9807C37Q41181813-C737B53B-B0D6-43A7-8D9B-DF1D10465469Q41500559-435D6B40-9542-4AD8-AD49-678108B489B4Q42234869-D0A3D4F6-1F06-47EC-8775-EE64220C34B8Q43216438-8985551D-7BA1-40D4-8E81-6AEABB93B200Q47107418-DD46F902-AD63-4668-8FFC-77F5D4923089Q48182692-737EDFC8-B1A2-4C17-A771-9CE2DE9DF872Q52765035-94F6E8BB-3505-4AA0-9C38-B8B43F18309DQ53550171-15E20D53-4A18-471A-BFF4-9DFC3AC6112AQ57462245-182D65D9-E168-4C97-A4ED-33CC67566232Q57832665-64249EAD-4BC3-4B4A-8494-E9A2698F365A
P2860
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Colorectal cancer in inflammat ...... nesis scientific workshop (I).
@en
type
label
Colorectal cancer in inflammat ...... nesis scientific workshop (I).
@en
prefLabel
Colorectal cancer in inflammat ...... nesis scientific workshop (I).
@en
P2093
P2860
P921
P1476
Colorectal cancer in inflammat ...... nesis scientific workshop (I).
@en
P2093
Andrea E van der Meulen-de Jong
Antonino Spinelli
Christoph Gasche
Elif Sarıtas Yuksel
Epameinondas Tsianos
Marc Marti-Gallostra
Murat Toruner
Pär Myrelid
Revital Kariv
Sandro Ardizzone
P2860
P356
10.1016/J.CROHNS.2013.04.008
P577
2013-05-09T00:00:00Z